Inflammaging as a prodrome to Alzheimer's disease (original) (raw)

References

  1. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S: Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007, 128: 92-105. 10.1016/j.mad.2006.11.016.
    CAS PubMed Google Scholar
  2. Salvioli S, Capri M, Valensin S, Tieri P, Monti D, Ottaviani E, Franceschi C: Inflamm-aging, cytokines and aging: State of the art, new hypotheses on the role of mitochondria and new perspectives from systems biology. Curr Pharm Des. 2006, 12: 3161-3171. 10.2174/138161206777947470.
    CAS PubMed Google Scholar
  3. De Martinis M, Franceschi C, Monti D, Ginaldi L: Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett. 2005, 579: 2035-2039. 10.1016/j.febslet.2005.02.055.
    CAS PubMed Google Scholar
  4. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, Monti D, Franceschi C, Paganelli R: Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol. 1993, 23: 2375-2378. 10.1002/eji.1830230950.
    CAS PubMed Google Scholar
  5. Franceschi C, Monti D, Sansoni P, Cossarizza A: The immunology of exceptional individuals: The lesson of centenarians. Immunol Today. 1995, 16: 12-16. 10.1016/0167-5699(95)80064-6.
    CAS PubMed Google Scholar
  6. Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafé M, Cavallone L, Marchegiani F, Olivieri F, Franceschi C, Caruso C: Inflammation, genetics, and longevity: Further studies on the protective effects in men of IL-10-1082 promoter SNP and its interaction with TNF-alpha -308 promoter SNP. J Med Genet. 2003, 40: 296-299. 10.1136/jmg.40.4.296.
    PubMed Central CAS PubMed Google Scholar
  7. Candore G, Colonna-Romano G, Balistreri CR, Di Carlo D, Grimaldi MP, Listì F, Nuzzo D, Vasto S, Lio D, Caruso C: Biology of longevity: Role of the innate immune system. Rejuvenation Res. 2006, 9: 143-148. 10.1089/rej.2006.9.143.
    CAS PubMed Google Scholar
  8. Vasto S, Candore G, Balistreri CR, Caruso M, Colonna-Romano G, Grimaldi MP, Listi F, Nuzzo D, Lio D, Caruso C: Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev. 2007, 128: 83-91. 10.1016/j.mad.2006.11.015.
    CAS PubMed Google Scholar
  9. Giunta S: Is inflammaging an auto[innate]immunity subclinical syndrome?. Immun Ageing. 2006, 3: 12-10.1186/1742-4933-3-12.
    PubMed Central PubMed Google Scholar
  10. Bruunsgaard H, Skinhoj P, Qvist J, Pedersen BK: Elderly humans show prolonged in vivo inflammatory activity during pneumococcal infections. J Infect Dis. 1999, 180: 551-554. 10.1086/314873.
    CAS PubMed Google Scholar
  11. Bruunsgaard H, Pedersen BK: The senile immune system. Ugeskr Laeger. 1999, 16: 4740-4743.
    Google Scholar
  12. Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhøj P, Pedersen BK: A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci. 1999, 54: M357-64.
    CAS PubMed Google Scholar
  13. Zanni F, Vescovini R, Biasini C, Fagnoni F, Zanlari L, Telera A, Di Pede P, Passeri G, Pedrazzoni M, Passeri M, Franceschi C, Sansoni P: Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: A contribution to understand the relationship between inflammation and immunosenescence. Exp Gerontol. 2003, 38: 981-987. 10.1016/S0531-5565(03)00160-8.
    CAS PubMed Google Scholar
  14. Giacconi R, Cipriano C, Albanese F, Boccoli G, Saba V, Olivieri F, Franceschi C, Mocchegiani E: The -174G/C polymorphism of IL-6 is useful to screen old subjects at risk for atherosclerosis or to reach successful ageing. Exp Gerontol. 2004, 39: 621-628. 10.1016/j.exger.2003.12.013.
    CAS PubMed Google Scholar
  15. Wikby A, Nilsson BO, Forsey R, Thompson J, Strindhall J, Löfgren S, Ernerudh J, Pawelec G, Ferguson F, Johansson B: The immune risk phenotype is associated with IL-6 in the terminal decline stage: Findings from the swedish NONA immune longitudinal study of very late life functioning. Mech Ageing Dev. 2006, 127: 695-704. 10.1016/j.mad.2006.04.003.
    CAS PubMed Google Scholar
  16. Mannucci PM, Mari D, Merati G, Peyvandi F, Tagliabue L, Sacchi E, Taioli E, Sansoni P, Bertolini S, Franceschi C: Gene polymorphisms predicting high plasma levels of coagulation and fibrinolysis proteins. A study in centenarians. Arterioscler Thromb Vasc Biol. 1997, 17: 755-759.
    CAS PubMed Google Scholar
  17. Mari D, Mannucci PM, Coppola R, Bottasso B, Bauer KA, Rosenbergm R: Hypercoagulability in centenarians: The paradox of successful aging. Blood. 1995, 85: 3144-3149.
    CAS PubMed Google Scholar
  18. Coppola R, Mari D, Lattuada A, Franceschi C: Von willebrand factor in italian centenarians. Haematologica. 2003, 88: 39-43.
    CAS PubMed Google Scholar
  19. Bonfigli AR, Sirolla C, Cenerelli S, Marra M, Boemi M, Franceschi C, Testa I, Mari D, Sacchi E, Testa R: Plasminogen activator inhibitor-1 plasma level increases with age in subjects with the 4G allele at position -675 in the promoter region. Thromb Haemost. 2004, 92: 1164-1165.
    CAS PubMed Google Scholar
  20. Bonafe M, Olivieri F, Cavallone L, Giovagnetti S, Mayegiani F, Cardelli M, Pieri C, Marra M, Antonicelli R, Lisa R, Rizzo MR, Paolisso G, Monti D, Franceschi C: A gender–dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur J Immunol. 2001, 31: 2357-2361. 10.1002/1521-4141(200108)31:8<2357::AID-IMMU2357>3.0.CO;2-X.
    CAS PubMed Google Scholar
  21. Cipriano C, Caruso C, Lio D, Giacconi R, Malavolta M, Muti E, Gasparini M, Franceschi C, Mocchegiani E: The -308G/A polymorphism of TNF-alpha influences immunological parameters in old subjects affected by infectious diseases. Int J Immunogenet. 2005, 32: 13-18. 10.1111/j.1744-313X.2005.00490.x.
    CAS PubMed Google Scholar
  22. Franceschi C, Bonafe M, Valensin S, Olivieri F, De Luca M, De Benedictis G: Inflamm-aging. an evolutionary perspective on immunosenescence. Ann N Y Acad Sci. 2000, 908: 244-254.
    CAS PubMed Google Scholar
  23. Aspinall R, Andrew D: Immunosenescence: Potential causes and strategies for reversal. Biochem Soc Trans. 2000, 28: 250-254.
    CAS PubMed Google Scholar
  24. Aspinall R: Longevity and the immune response. Biogerontology. 2000, 1: 273-278. 10.1023/A:1010046532657.
    CAS PubMed Google Scholar
  25. Linton PJ, Li SP, Zhang Y, Bautista B, Huynh Q, Trinh T, Linton PJ: Intrinsic versus environmental influences on T-cell responses in aging. Immunol Rev. 2005, 205: 207-219. 10.1111/j.0105-2896.2005.00266.x.
    CAS PubMed Google Scholar
  26. Allman D, Miller JP: B cell development and receptor diversity during aging. Curr Opin Immunol. 2005, 17: 463-467.
    CAS PubMed Google Scholar
  27. Effros RB, Dagarag M, Spaulding C, Man J: The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev. 2005, 205: 147-157. 10.1111/j.0105-2896.2005.00259.x.
    CAS PubMed Google Scholar
  28. Pawelec G: When T cells get old. Sci Aging Knowledge Environ. 2005, 2005 (50): pe39-10.1126/sageke.2005.50.pe39.
    PubMed Google Scholar
  29. Fann M, Chiu WK, Wood WH, Levine BL, Becker KG, Weng NP: Gene expression characteristics of CD28null memory phenotype CD8+ T cells and its implication in T-cell aging. Immunol Rev. 2005, 205: 190-206. 10.1111/j.0105-2896.2005.00262.x.
    CAS PubMed Google Scholar
  30. Weng NP: Aging of the immune system: How much can the adaptive immune system adapt?. Immunity. 2006, 24: 495-499. 10.1016/j.immuni.2006.05.001.
    PubMed Central CAS PubMed Google Scholar
  31. Cossarizza A, Ortolani C, Paganelli R, Barbieri D, Monti D, Sansoni P, Fagiolo U, Castellani G, Bersani F, Londei M, Franceschi C: CD45 isoforms expression on CD4+ and CD8+ T cells throughout life, from newborns to centenarians: Implications for T cell memory. Mech Ageing Dev. 1996, 86: 173-195. 10.1016/0047-6374(95)01691-0.
    CAS PubMed Google Scholar
  32. Solana R, Pawelec G, Tarazona R: Aging and innate immunity. Immunity. 2006, 24: 491-494. 10.1016/j.immuni.2006.05.003.
    CAS PubMed Google Scholar
  33. Tarazona R, DelaRosa O, Alonso C, Ostos B, Espejo J, Pena J, Solana R: Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev. 2000, 121: 77-88. 10.1016/S0047-6374(00)00199-8.
    CAS PubMed Google Scholar
  34. Khan N, Shariff N, Cobbold M, Bruton R, Ainsworth JA, Sinclair AJ, Nayak L, Moss PA: Cytomegalovirus seropositivity drives the CD8 T cell repertoire toward greater clonality in healthy elderly individuals. J Immunol. 2002, 169: 1984-1992.
    CAS PubMed Google Scholar
  35. Koch S, Solana R, Dela Rosa O, Pawelec G: Human cytomegalovirus infection and T cell immunosenescence: A mini review. Mech Ageing Dev. 2006, 127: 538-543. 10.1016/j.mad.2006.01.011.
    CAS PubMed Google Scholar
  36. Ouyang Q, Wagner WM, Voehringer D, Wikby A, Klatt T, Walter S, Muller CA, Pircher H, Pawelec G: Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp Gerontol. 2003, 38: 911-920. 10.1016/S0531-5565(03)00134-7.
    CAS PubMed Google Scholar
  37. Vsecovini R, Telera A, Fagnoni FF, Biasini C, Medici MC, Valcavi P, di Pede P, Lucchini G, Zanlari L, Passeri G, Zanni F, Chezzi C, Franchesci C, Sansoni P: Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8+ T cells. Exp Gerontol. 2004, 39: 1233-1243. 10.1016/j.exger.2004.04.004.
    Google Scholar
  38. Ouyang Q, Wanger WM, Wikby A, Walter S, Aubert G, Dodi AI, Travers P, Pawelec G: Large numbers of dysfunctional CD8+ T lymphocytes bearing receptors for a single dominant CMV epitope in the very old. J Clin Immunol. 2003, 23: 247-257. 10.1023/A:1024580531705.
    CAS PubMed Google Scholar
  39. Franceschi C, Valensin S, Fagnoni F, Barbi C, Bonafe M: Biomarkers of immunosenescence within an evolutionary perspective: The challenge of heterogeneity and the role of antigenic load. Exp Gerontol. 1999, 34: 911-921. 10.1016/S0531-5565(99)00068-6.
    CAS PubMed Google Scholar
  40. Goronzy JJ, Weyand CM: T cell development and receptor diversity during aging. Curr Opin Immunol. 2005, 17: 468-475.
    CAS PubMed Google Scholar
  41. Swain S, Clise-Dwyer K, Haynes L: Homeostasis and the age-associated defect of CD4 T cells. Semin Immunol. 2005, 17: 370-377. 10.1016/j.smim.2005.05.007.
    PubMed Central CAS PubMed Google Scholar
  42. Kovaiou RD, Weiskirchner I, Keller M, Pfister G, Cioca DP, Grubeck-Loebensten B: Age-related differences in phenotype and function of CD4+ T cells are due to a phenotypic shift from naive to memory effector CD4+ T cells. Int Immunol. 2005, 17: 1359-1366. 10.1093/intimm/dxh314.
    CAS PubMed Google Scholar
  43. Haynes L, Eaton SM, Burns EM, Randall TD, Swain SL: Newly generated CD4 T cells in aged animals do not exhibit age-related defects in response to antigen. J Exp Med. 2005, 201: 845-851. 10.1084/jem.20041933.
    PubMed Central CAS PubMed Google Scholar
  44. Kang I, Hong MS, Nolasco H, Park SH, Dan JM, Choi JY, Craft Kang I: Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J Immunol. 2004, 173: 673-681.
    CAS PubMed Google Scholar
  45. Almanzar G, Schwaiger S, Jenewein B, Keller M, Herndler-Brandstetter D, Wurzner R, Schonitzer D, Grubeck-Lobenstein B: Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol. 2005, 79: 3675-3683. 10.1128/JVI.79.6.3675-3683.2005.
    PubMed Central CAS PubMed Google Scholar
  46. Azuma M, Phillips JH, Lanier LL: CD28- T lymphocytes. antigenic and functional properties. J Immunol. 1993, 150: 1147-1159.
    CAS PubMed Google Scholar
  47. Effros RB, Dagarag M, Spaulding C, Man J: The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev. 2005, 205: 147-157. 10.1111/j.0105-2896.2005.00259.x.
    CAS PubMed Google Scholar
  48. Tarazona R, DelaRosa O, Alonso C, Ostos B, Espejo J, Pena J, Solana R: Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech Ageing Dev. 2000, 121: 77-88. 10.1016/S0047-6374(00)00199-8.
    CAS PubMed Google Scholar
  49. Pawelec G, Akbar A, Caruso C, Solana R, Grubeck-Loebenstein B, Wikby A, Pawelec G: Human immunosenescence: Is it infectious?. Immunol Rev. 2005, 205: 257-268. 10.1111/j.0105-2896.2005.00271.x.
    CAS PubMed Google Scholar
  50. Fann M, Chiu WK, Wood WH, Levine BL, Becker KG, Weng NP: Gene expression characteristics of CD28null memory phenotype CD8+ T cells and its implication in T-cell aging. Immunol Rev. 2005, 205: 190-206. 10.1111/j.0105-2896.2005.00262.x.
    CAS PubMed Google Scholar
  51. Almanzar G, Schwaiger S, Jenewein B, Keller M, Herndler-Brandstetter D, Wurzner R, Schonitzer D, Grubeck-Loebenstein B: Long-term cytomegalovirus infection leads to significant changes in the composition of the CD8+ T-cell repertoire, which may be the basis for an imbalance in the cytokine production profile in elderly persons. J Virol. 2005, 79: 3675-3683. 10.1128/JVI.79.6.3675-3683.2005.
    PubMed Central CAS PubMed Google Scholar
  52. Ghia P, Melchers F, Rolink AG: Age-dependent changes in B lymphocyte development in man and mouse. Exp Gerontol. 2000, 35: 159-165. 10.1016/S0531-5565(99)00095-9.
    CAS PubMed Google Scholar
  53. Szabo P, Shen S, Weksler ME: Age-associated defects in B lymphocyte development. Exp Gerontol. 1999, 34: 431-434. 10.1016/S0531-5565(99)00023-6.
    CAS PubMed Google Scholar
  54. Weksler ME: Changes in the B-cell repertoire with age. Vaccine. 2000, 18: 1624-1628. 10.1016/S0264-410X(99)00497-1.
    CAS PubMed Google Scholar
  55. Yang X, Stedra J, Cerny J: Relative contribution of T and B cells to hypermutation and selection of the antibody repertoire in germinal centers of aged mice. J Exp Med. 1996, 183: 959-970. 10.1084/jem.183.3.959.
    CAS PubMed Google Scholar
  56. Zheng B, Han S, Takahashi Y, Kelsoe G: Immunosenescence and germinal center reaction. Immunol Rev. 1997, 160: 63-77. 10.1111/j.1600-065X.1997.tb01028.x.
    CAS PubMed Google Scholar
  57. Kraft R, Bachmann M, Bachmann K, Buerki H, Hess MW, Cottier H, Stoner RD: Satisfactory primary tetanus antitoxin responses but markedly reduced germinal centre formation in first draining lymph nodes of ageing mice. Clin Exp Immunol. 1987, 67: 447-453.
    PubMed Central CAS PubMed Google Scholar
  58. Franceschi C, Cossarizza A: Introduction: The reshaping of the immune system with age. Int Rev Immunol. 1995, 12: 1-4. 10.3109/08830189509056697.
    CAS PubMed Google Scholar
  59. Frasca D, Riley RL, Blomberg BB: Humoral immune response and B-cell functions including immunoglobulin class switch are downregulated in aged mice and humans. Semin Immunol. 2005, 17: 378-384. 10.1016/j.smim.2005.05.005.
    CAS PubMed Google Scholar
  60. Uyemura K, Castle SC, Makinodan T: The frail elderly: Role of dendritic cells in the susceptibility of infection. Mech Ageing Dev. 2002, 123: 955-962. 10.1016/S0047-6374(02)00033-7.
    CAS PubMed Google Scholar
  61. Perlmutter LS, Scott SA, Barron E, Chui HC: MHC class II-positive microglia in human brain: Association with alzheimer lesions. J Neurosci Res. 1992, 33: 549-558. 10.1002/jnr.490330407.
    CAS PubMed Google Scholar
  62. O'Brien K, Fitzgerald DC, Naiken K, Alugupalli KR, Rostami AM, Gran B: Role of the innate immune system in autoimmune inflammatory demyelination. Curr Med Chem. 2008, 15: 1105-1115. 10.2174/092986708784221458.
    PubMed Google Scholar
  63. Brehin AC, Mouries J, Frenkiel MP, Dadaglio G, Despres P, Lafon M, Couderc T: Dynamics of immune cell recruitment during west nile encephalitis and identification of a new CD19+B220-BST-2+ leukocyte population. J Immunol. 2008, 180: 6760-6767.
    CAS PubMed Google Scholar
  64. Herrero C, Marques L, Lloberas J, Celada A: IFN-gamma-dependent transcription of MHC class II IA is impaired in macrophages from aged mice. J Clin Invest. 2001, 107: 485-493. 10.1172/JCI11696.
    PubMed Central CAS PubMed Google Scholar
  65. Plowden J, Renshaw-Hoelscher M, Engleman C, Katz J, Sambhara S: Innate immunity in aging: Impact on macrophage function. Aging Cell. 2004, 3: 161-167. 10.1111/j.1474-9728.2004.00102.x.
    CAS PubMed Google Scholar
  66. Cumberbatch M, Dearman RJ, Kimber I: Influence of ageing on langerhans cell migration in mice: Identification of a putative deficiency of epidermal interleukin-1beta. Immunology. 2002, 105: 466-477. 10.1046/j.1365-2567.2002.01381.x.
    PubMed Central CAS PubMed Google Scholar
  67. Tan J, Town T, Crawford F, Mori T, DelleDonne A, Crescentini R, Obregon D, Flavell RA, Mullan MJ: Role of CD40 ligand in amyloidosis in transgenic alzheimer's mice. Nat Neurosci. 2002, 5: 1288-1293. 10.1038/nn968.
    CAS PubMed Google Scholar
  68. Medzhitov R, Janeway C: Innate immunity. N Engl J Med. 2000, 343: 338-344. 10.1056/NEJM200008033430506.
    CAS PubMed Google Scholar
  69. Krieger M: The other side of scavenger receptors: Pattern recognition for host defense. Curr Opin Lipidol. 1997, 8: 275-280.
    CAS PubMed Google Scholar
  70. Muzio M, Natoli G, Saccani S, Levrero M, Mantovani A: The human toll signaling pathway: Divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med. 1998, 187: 2097-2101. 10.1084/jem.187.12.2097.
    PubMed Central CAS PubMed Google Scholar
  71. Guha M, Mackman N: LPS induction of gene expression in human monocytes. Cell Signal. 2001, 13: 85-94. 10.1016/S0898-6568(00)00149-2.
    CAS PubMed Google Scholar
  72. Fagiolo U, Cossarizza A, Scala E, Fanales-Belasio E, Ortolani C, Cozzi E, Monti D, Franceschi C, Paganelli R: Increased cytokine production in mononuclear cells of healthy elderly people. Eur J Immunol. 1993, 23: 2375-2378. 10.1002/eji.1830230950.
    CAS PubMed Google Scholar
  73. Ershler WB, Sun WH, Binkley N, Gravenstein S, Volk MJ, Kamoske G, Klopp RG, Roecker EB, Daynes RA, Weindruch R: Interleukin-6 and aging: Blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res. 1993, 12: 225-230.
    CAS PubMed Google Scholar
  74. Clark JA, Peterson TC: Cytokine production and aging: Overproduction of IL-8 in elderly males in response to lipopolysaccharide. Mech Ageing Dev. 1994, 77: 127-139. 10.1016/0047-6374(94)90020-5.
    CAS PubMed Google Scholar
  75. O'Mahony L, Holland J, Jackson J, Feighery C, Hennessy TP, Mealy K: Quantitative intracellular cytokine measurement: Age-related changes in proinflammatory cytokine production. Clin Exp Immunol. 1998, 113: 213-219. 10.1046/j.1365-2249.1998.00641.x.
    PubMed Central PubMed Google Scholar
  76. Roubenoff R, Harris TB, Abad LW, Wilson PW, Dallal GE, Dinarello CA: Monocyte cytokine production in an elderly population: Effect of age and inflammation. J Gerontol A Biol Sci Med Sci. 1998, 53: M20-6.
    CAS PubMed Google Scholar
  77. Sadeghi HM, Schnelle JF, Thoma JK, Nishanian P, Fahey JL: Phenotypic and functional characteristics of circulating monocytes of elderly persons. Exp Gerontol. 1999, 34: 959-970. 10.1016/S0531-5565(99)00065-0.
    CAS PubMed Google Scholar
  78. Hasegawa Y, Sawada M, Ozaki N, Inagaki T, Suzumura A: Increased soluble tumor necrosis factor receptor levels in the serum of elderly people. Gerontology. 2000, 46: 185-188. 10.1159/000022157.
    CAS PubMed Google Scholar
  79. Mariani E, Meneghetti A, Neri S, Ravaglia G, Forti P, Cattini L, Facchini A: Chemokine production by natural killer cells from nonagenarians. Eur J Immunol. 2002, 32: 1524-1529. 10.1002/1521-4141(200206)32:6<1524::AID-IMMU1524>3.0.CO;2-E.
    CAS PubMed Google Scholar
  80. Hayek MG, Mura C, Wu D, Beharka AA, Han SN, Paulson KE, Hwang D, Meydani SN: Enhanced expression of inducible cyclooxygenase with age in murine macrophages. J Immunol. 1997, 159: 2445-2451.
    CAS PubMed Google Scholar
  81. Saurwein-Teissl M, Lung TL, Marx F, Gschosser C, Asch E, Blasko I, Parson W, Bock G, Schonitzer D, Trannoy E, Grubeck-Loebenstein B: Lack of antibody production following immunization in old age: Association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol. 2002, 168: 5893-5899.
    CAS PubMed Google Scholar
  82. Bandres E, Merino J, Vazquez B, Inoges S, Moreno C, Subira ML, Sanchez-Ibarrola A: The increase of IFN-gamma production through aging correlates with the expanded CD8(+high)CD28(-)CD57(+) subpopulation. Clin Immunol. 2000, 96: 230-235. 10.1006/clim.2000.4894.
    CAS PubMed Google Scholar
  83. Sakata-Kaneko S, Wakatsuki Y, Matsunaga Y, Usui T, Kita T: Altered Th1/Th2 commitment in human CD4+ T cells with ageing. Clin Exp Immunol. 2000, 120: 267-273. 10.1046/j.1365-2249.2000.01224.x.
    PubMed Central CAS PubMed Google Scholar
  84. Karanfilov CI, Liu B, Fox CC, Lakshmanan RR, Whisler RL: Age-related defects in Th1 and Th2 cytokine production by human T cells can be dissociated from altered frequencies of CD45RA+ and CD45RO+ T cell subsets. Mech Ageing Dev. 1999, 109: 97-112. 10.1016/S0047-6374(99)00030-5.
    CAS PubMed Google Scholar
  85. Mbawuike IN, Acuna CL, Walz KC, Atmar RL, Greenberg SB, Couch RB: Cytokines and impaired CD8+ CTL activity among elderly persons and the enhancing effect of IL-12. Mech Ageing Dev. 1997, 94: 25-39. 10.1016/S0047-6374(96)01855-6.
    CAS PubMed Google Scholar
  86. Rink L, Cakman I, Kirchner H: Altered cytokine production in the elderly. Mech Ageing Dev. 1998, 102: 199-209. 10.1016/S0047-6374(97)00153-X.
    CAS PubMed Google Scholar
  87. Bernstein ED, Gardner EM, Abrutyn E, Gross P, Murasko DM: Cytokine production after influenza vaccination in a healthy elderly population. Vaccine. 1998, 16: 1722-1731. 10.1016/S0264-410X(98)00140-6.
    CAS PubMed Google Scholar
  88. Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA: The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med. 1995, 123: 518-527.
    CAS PubMed Google Scholar
  89. Nichol KL, Margolis KL, Wuorenma J, von Sternberg T: The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med. 1994, 331: 778-784. 10.1056/NEJM199409223311206.
    CAS PubMed Google Scholar
  90. Saurwein-Teissl M, Lung TL, Marx F, Gschosser C, Asch E, Blasko I, Parson W, Bock G, Schonitzer D, Trannoy E, Grubeck-Loebenstein B: Lack of antibody production following immunization in old age: Association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol. 2002, 168: 5893-5899.
    CAS PubMed Google Scholar
  91. McGeer PL, McGeer EG: Anti-inflammatory drugs in the fight against alzheimer's disease. Ann N Y Acad Sci. 1996, 777: 213-220. 10.1111/j.1749-6632.1996.tb34421.x.
    CAS PubMed Google Scholar
  92. McGeer PL, McGeer EG: The inflammatory response system of brain: Implications for therapy of alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev. 1995, 21: 195-218. 10.1016/0165-0173(95)00011-9.
    CAS PubMed Google Scholar
  93. Shoenfeld Y, Sherer Y, Harats D: Artherosclerosis as an infectious, inflammatory and autoimmune disease. Trends Immunol. 2001, 22: 293-295. 10.1016/S1471-4906(01)01922-6.
    CAS PubMed Google Scholar
  94. Nguyen TT, Cho SO, Ban JY, Kim JY, Ju HS, Koh SB, Song KS, Seong YH: Neuroprotective Effect of Sanguisorbae Radix against Oxidative Stress-Induced Brain Damage: in Vitro and in Vivo. Biol Pharm Bull. 2008, 31: 2028-35. 10.1248/bpb.31.2028.
    CAS PubMed Google Scholar
  95. Smith M, Richey P, Taneda S, Kutty R, Sayre L, Monnier V, Perry G: Advanced Maillard reaction end products, free radicals, and protein oxidation in Alzheimer's disease. Ann N Y Acad Sci. 1994, 738: 447-454.
    CAS PubMed Google Scholar
  96. Smith M, Sayre L, Monnier V, Perry G: Radical AGEing in Alzheimer's disease. Trends Neurosci. 1995, 18: 172-176. 10.1016/0166-2236(95)93897-7.
    CAS PubMed Google Scholar
  97. Smith M, Rudnicka-Nawro M, Richey P, Praprotnik D, Mulvihill P, Miller C, Sayre L, Perry G: Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J Neurochem. 1995, 64: 2660-2666.
    CAS PubMed Google Scholar
  98. Smith M, Perry G, Richey P, Sayre L, Anderson V, Beal M, Kowall N: Oxidative damage in Alzheimer's. Nature. 1996, 382: 120-121. 10.1038/382120b0.
    CAS PubMed Google Scholar
  99. Smith M, Harris P, Sayre L, Perry G: Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci. 1997, 94: 9866-9868. 10.1073/pnas.94.18.9866.
    PubMed Central CAS PubMed Google Scholar
  100. Smith M, Richey Harris P, Sayre L, Beckman J, Perry G: Widespread peroxynitrite-mediated damage in Alzheimer's disease. J Neurosci. 1997, 17 (8): 2653-2657.
    CAS PubMed Google Scholar
  101. Cras M, Kawai S, Siedlak P, Mulvihill P, Gambetti D, Lowery P, Gonzalez-DeWhitt B, Perry G: Neuronal and microglial involvement in beta-amyloid protein deposition in Alzheimer's disease. Am J Pathol. 1990, 137: 241-246.
    PubMed Central CAS PubMed Google Scholar
  102. Colton C, Gilbert D: Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett. 1987, 223: 284-288. 10.1016/0014-5793(87)80305-8.
    CAS PubMed Google Scholar
  103. Good P, Werner P, Hsu A, Olanow C, Perl D: Evidence of neuronal oxidative damage in Alzheimer's disease. Am J Pathol. 1996, 149: 21-28.
    PubMed Central CAS PubMed Google Scholar
  104. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, Streit W, Strohmeyer R, Tooyoma I, Van Muiswinkel FL, Veerhuis R, Walker D, Webster S, Wegrzyniak B, Wenk G, Wyss-Coray T: Inflammation and alzheimer's disease. Neurobiol Aging. 2000, 21: 383-421. 10.1016/S0197-4580(00)00124-X.
    PubMed Central CAS PubMed Google Scholar
  105. Nunomura A, Perry G, Aliev G, Hirai K, Takeda A, Balraj EK, Jones PK, Ghanbari H, Wataya T, Shimohama S, Chiba S, Atwood CS, Petersen RB, Smith MA: Oxidative damage is the earliest event in Alzheimer disease. J Neuropathol Exp Neurol. 2001, 60: 759-67.
    CAS PubMed Google Scholar
  106. Richartz-Salzburger E, Batra A, Stransky E, Laske C, Kohler N, Bartels M, Buchkremer G, Schott K: Altered lymphocyte distribution in alzheimer's disease. J Psychiatr Res. 2007, 41: 174-178. 10.1016/j.jpsychires.2006.01.010.
    PubMed Google Scholar
  107. Smith M, Hirai K, Hsiao K, Pappolla M, Harris P, Siedlak S, Tabaton M, Perry G: Amyloid-beta deposition in Alzheimer transgenic mice is associated with oxidative stress. J Neurochem. 1998, 70: 2212-2215.
    CAS PubMed Google Scholar
  108. Butterfield A, Poon H, St Clair D, Keller J, Pierce W, Klein J, Markesbery W: Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease. Neurobiol Dis. 2006, 22: 223-232. 10.1016/j.nbd.2005.11.002.
    CAS PubMed Google Scholar
  109. Keller J, Schmitt F, Scheff S, Ding Q, Chen Q, Butterfield D, Markesbery W: Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology. 2005, 64: 1152-1156.
    CAS PubMed Google Scholar
  110. Butterfield D, Reed T, Perluigi M, De Marco C, Coccia R, Cini C, Sultana R: Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment. Neurosci Lett. 2006, 397: 170-173. 10.1016/j.neulet.2005.12.017.
    CAS PubMed Google Scholar
  111. Smith M, Kutty R, Richey P, Yan S, Stern D, Chader G, Wiggert B, Petersen R, Perry G: Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol. 1994, 145: 42-47.
    PubMed Central CAS PubMed Google Scholar
  112. Lue LF, Brachova L, Civin WH, Rogers J: Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of alzheimer's disease neurodegeneration. J Neuropathol Exp Neurol. 1996, 55: 1083-1088.
    CAS PubMed Google Scholar
  113. Webster S, Lue LF, Brachova L, Tenner AJ, McGeer PL, Terai K, Walker DG, Bradt B, Cooper NR, Rogers J: Molecular and cellular characterization of the membrane attack complex, C5b-9, in alzheimer's disease. Neurobiol Aging. 1997, 18: 415-421. 10.1016/S0197-4580(97)00042-0.
    CAS PubMed Google Scholar
  114. Blasko I, Knaus G, Weiss E, Kemmler G, Winkler C, Falkensammer G, Griesmacher A, Wurzner R, Marksteiner J, Fuchs D: Cognitive deterioration in alzheimer's disease is accompanied by increase of plasma neopterin. J Psychiatr Res. 2007, 41: 694-701. 10.1016/j.jpsychires.2006.02.001.
    PubMed Google Scholar
  115. Mrak RE, Griffin WS: Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging. 2005, 26: 349-354. 10.1016/j.neurobiolaging.2004.05.010.
    CAS PubMed Google Scholar
  116. Blasko I, Stampfer-Kountchev M, Robatscher P, Veerhuis R, Eikelenboom P, Grubeck-Loebenstein B: How chronic inflammation can affect the brain and support the development of alzheimer's disease in old age: The role of microglia and astrocytes. Aging Cell. 2004, 3: 169-176. 10.1111/j.1474-9728.2004.00101.x.
    CAS PubMed Google Scholar
  117. Franceschi C, Bonafe M: Centenarians as a model for healthy aging. Biochem Soc Trans. 2003, 31: 457-461. 10.1042/BST0310457.
    CAS PubMed Google Scholar
  118. Franceschi C, Capri M, Monti D, Giunta S, Olivieri F, Sevini F, Panourgia MP, Invidia L, Celani L, Scurti M, Cevenini E, Castellani GC, Salvioli S: Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev. 2007, 128: 92-105. 10.1016/j.mad.2006.11.016.
    CAS PubMed Google Scholar
  119. Mutus B, Rabini RA, Franceschi C, Paolisso G, Rizzo MR, Ragno E, Rappelli A, Braconi M, Mazzanti L: Cellular resistance to homocysteine: A key for longevity. Atherosclerosis. 2000, 152: 527-528. 10.1016/S0021-9150(00)00546-3.
    CAS PubMed Google Scholar
  120. Rabini RA, Vignini A, Martarelli D, Nanetti L, Salvolini E, Rizzo MR, Ragno E, Paolisso G, Franceschi C, Mazzanti L: Evidence for reduction of pro-atherosclerotic properties in platelets from healthy centenarians. Exp Gerontol. 2003, 38: 367-371. 10.1016/S0531-5565(02)00268-1.
    CAS PubMed Google Scholar
  121. Nanetti L, Vignini A, Moroni C, Bartolini M, Luzzi S, Provinciali L, Mazzanti L: Peroxynitrite production and NOS expression in astrocytes U373MG incubated with lipoproteins from alzheimer patients. Brain Res. 2005, 1054: 38-44. 10.1016/j.brainres.2005.06.025.
    CAS PubMed Google Scholar
  122. Nanetti L, Moroni C, Vignini A, Vannini P, Franceschi C, Mazzanti L: Age-related changes on platelet membrane: A study on elderly and centenarian monozygotic twins. Exp Gerontol. 2005, 40: 519-525. 10.1016/j.exger.2005.07.002.
    CAS PubMed Google Scholar
  123. Kario K, Matsuo T: Relation between sialic acid concentrations and the haemostatic system in the elderly. BMJ. 1993, 306: 1650-1651.
    PubMed Central CAS PubMed Google Scholar
  124. Troiano L, Pini G, Petruzzi E, Ognibene A, Franceschi C, Monti D, Masotti G, Cilotti A, Forti G: Evaluation of adrenal function in aging. J Endocrinol Invest. 1999, 22: 74-75.
    CAS PubMed Google Scholar
  125. Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafe M, Cavallone L, Franceschi C, Caruso C: Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immun. 2002, 3: 30-33. 10.1038/sj.gene.6363827.
    CAS PubMed Google Scholar
  126. Lio D, Licastro F, Scola L, Chiappelli M, Grimaldi LM, Crivello A, Colonna-Romano G, Candore G, Franceschi C, Caruso C: Interleukin-10 promoter polymorphism in sporadic alzheimer's disease. Genes Immun. 2003, 4: 234-238. 10.1038/sj.gene.6363964.
    CAS PubMed Google Scholar
  127. Richartz-Salzburger E, Batra A, Stransky E, Laske C, Kohler N, Bartels M, Buchkremer G, Schott K: Altered lymphocyte distribution in alzheimer's disease. J Psychiatr Res. 2007, 41: 174-178. 10.1016/j.jpsychires.2006.01.010.
    PubMed Google Scholar
  128. Murr C, Hainz U, Asch E, Berger P, Jenewein B, Saurwein-Teissl M, Grubeck-Loebenstein B, Fuchs D: Association of increased neopterin production with decreased humoral immunity in the elderly. Exp Gerontol. 2003, 38: 583-587. 10.1016/S0531-5565(03)00062-7.
    CAS PubMed Google Scholar
  129. Wirleitner B, Schroecksnadel K, Winkler C, Fuchs D: Neopterin in HIV-1 infection. Mol Immunol. 2005, 42: 183-194. 10.1016/j.molimm.2004.06.017.
    CAS PubMed Google Scholar
  130. Blasko I, Knaus G, Weiss E, Kemmler G, Winkler C, Falkensammer G, Griesmacher A, Wurzner R, Marksteiner J, Fuchs D: Cognitive deterioration in alzheimer's disease is accompanied by increase of plasma neopterin. J Psychiatr Res. 2007, 41: 694-701. 10.1016/j.jpsychires.2006.02.001.
    PubMed Google Scholar
  131. Leblhuber F, Walli J, Demel U, Tilz GP, Widner B, Fuchs D: Increased serum neopterin concentrations in patients with alzheimer's disease. Clin Chem Lab Med. 1999, 37: 429-431. 10.1515/CCLM.1999.070.
    CAS PubMed Google Scholar
  132. Hull M, Pasinetti GM, Aisen PS: Elevated plasma neopterin levels in alzheimer disease. Alzheimer Dis Assoc Disord. 2000, 14: 228-230. 10.1097/00002093-200010000-00007.
    CAS PubMed Google Scholar
  133. Ikeda T, Yamamoto K, Takahashi K, Yamada M: Immune system-associated antigens on the surface of peripheral blood lymphocytes in patients with alzheimer's disease. Acta Psychiatr Scand. 1991, 83: 444-448. 10.1111/j.1600-0447.1991.tb05573.x.
    CAS PubMed Google Scholar
  134. Singh VK: Studies of neuroimmune markers in alzheimer's disease. Mol Neurobiol. 1994, 9: 73-81. 10.1007/BF02816106.
    CAS PubMed Google Scholar
  135. Skias D, Bania M, Reder AT, Luchins D, Antel JP: Senile dementia of alzheimer's type (SDAT): Reduced T8+-cell-mediated suppressor activity. Neurology. 1985, 35: 1635-1638.
    CAS PubMed Google Scholar
  136. Singh VK, Fudenberg HH, Brown FR: Immunologic dysfunction: Simultaneous study of alzheimer's and older down's patients. Mech Ageing Dev. 1986, 37: 257-264. 10.1016/0047-6374(86)90043-6.
    PubMed Google Scholar
  137. Leffell MS, Lumsden L, Steiger WA: An analysis of T lymphocyte subpopulations in patients with alzheimer's disease. J Am Geriatr Soc. 1985, 33: 4-8.
    CAS PubMed Google Scholar
  138. Shalit F, Sredni B, Brodie C, Kott E, Huberman M: T lymphocyte subpopulations and activation markers correlate with severity of alzheimer's disease. Clin Immunol Immunopathol. 1995, 75: 246-250. 10.1006/clin.1995.1078.
    CAS PubMed Google Scholar
  139. Trieb K, Ransmayr G, Sgonc R, Lassmann H, Grubeck-Loebenstein B: APP peptides stimulate lymphocyte proliferation in normals, but not in patients with alzheimer's disease. Neurobiol Aging. 1996, 17: 541-547. 10.1016/0197-4580(96)00068-1.
    CAS PubMed Google Scholar
  140. Singh VK: tudies of neuroimmune markers in alzheimer's disease. Mol Neurobiol. 1994, 9: 73-81. 10.1007/BF02816106.
    CAS PubMed Google Scholar
  141. Xu J, Hong Y, Shen W, Wang L, Di Q, Zhang Y, Sun Y, Xu W, Hu X: P1–369: The impaired suppression function of peripheral blood CD4+ CD25hi regulatory T cells in patients with Alzheimer's disease. Alz and dementia. 2008, 4: T327-10.1016/j.jalz.2008.05.951.
    Google Scholar
  142. Schindowski K, Peters J, Gorriz C, Schramm U, Weinandi T, Leutner S, Maurer K, Frolich L, Muller WE, Eckert A: Apoptosis of CD4+ T and natural killer cells in alzheimer's disease. Pharmacopsychiatry. 2006, 39: 220-228. 10.1055/s-2006-954591.
    CAS PubMed Google Scholar
  143. Sastre M, Dewachter I, Landreth GE, Willson TM, Klockgether T, van Leuven F, Heneka MT: Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase. J Neurosci. 2003, 23: 9796-9804.
    CAS PubMed Google Scholar
  144. Blasko I, Marx F, Steiner E, Hartmann T, Grubeck-Loebenstein B: TNFalpha plus IFNgamma induce the production of alzheimer beta-amyloid peptides and decrease the secretion of APPs. FASEB J. 1999, 13: 63-68.
    CAS PubMed Google Scholar
  145. Mackic JB, Bading J, Ghiso J, Walker L, Wisniewski T, Frangione B, Zlokovic BV: Circulating amyloid-beta peptide crosses the blood-brain barrier in aged monkeys and contributes to alzheimer's disease lesions. Vascul Pharmacol. 2002, 38: 303-313. 10.1016/S1537-1891(02)00198-2.
    CAS PubMed Google Scholar
  146. Zlokovic BV, Deane R, Sallstrom J, Chow N, Miano JM: Neurovascular pathways and alzheimer amyloid beta-peptide. Brain Pathol. 2005, 15: 78-83.
    CAS PubMed Google Scholar
  147. Zhu X, Lee HG, Perry G, Smith MA: Alzheimer disease, the two-hit hypothesis: an update. Biochim Biophys Acta. 2007, 1772: 494-502.
    CAS PubMed Google Scholar
  148. Nagy Z, Esiri M, Smith A: Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions. Acta Neuropathol (Berl). 1997, 93: 294-300. 10.1007/s004010050617.
    CAS Google Scholar
  149. McShea A, Harris P, Webster K, Wahl A, Smith M: Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease. Am J Pathol. 1997, 150: 1933-1939.
    PubMed Central CAS PubMed Google Scholar
  150. Vincent J, Zheng D, Dickson D, Kress Y, Davies P: Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's disease. Neurobiol Aging. 1998, 19: 287-296. 10.1016/S0197-4580(98)00071-2.
    CAS PubMed Google Scholar
  151. Yang Y, Mufson E, Herrup K: Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. J Neurosci. 2003, 23: 2557-2563.
    CAS PubMed Google Scholar
  152. McGeer PL, Schulzer M, McGeer EG: Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology. 1996, 47: 425-432.
    CAS PubMed Google Scholar
  153. Breitner JC, Gau BA, Welsh KA: Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology. 1994, 44: 227-232.
    CAS PubMed Google Scholar
  154. Breitner JCS, Welsh KA, Helms MJ: Delayed onset of Alzheimer's disease with nonsteroidal anti-inflammatory and histamine H2 blocking drugs. Neurobiol Aging. 1995, 16: 523-530. 10.1016/0197-4580(95)00049-K.
    CAS PubMed Google Scholar
  155. Rogers J, Kirby LC, Hempelman SR: Clinical trial of indomethacin in Alzheimer's disease. Neurology. 1993, 43: 1609-1611.
    CAS PubMed Google Scholar
  156. Scharf S, Mander A, Ugoni A: A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease. Neurology. 1999, 53: 197-201.
    CAS PubMed Google Scholar
  157. Aisen PS, Davis KL, Berg JD: A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology. 2000, 54: 588-593.
    CAS PubMed Google Scholar
  158. Aisen PS, Schafer KA, Grundman M: Effects of rofecoxib or naproxen versus placebo on Alzheimer disease progression: a randomized controlled trial. JAMA. 2003, 289: 2819-2826. 10.1001/jama.289.21.2819.
    CAS PubMed Google Scholar
  159. Thal LJ, Ferris SH, Kirby L: A randomized, double-blind, study of rofecoxib in patients with mild cognitive impairment. Neuropsychopharmacology. 2005, 30: 1204-1215. 10.1038/sj.npp.1300690.
    CAS PubMed Google Scholar
  160. Group AR, Lyketsos CG, Breitner JC: Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology. 2007, 68: 1800-1808. 10.1212/01.wnl.0000260269.93245.d2.
    Google Scholar
  161. van Gool WA, Weinstein HC, Scheltens PK: Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo- controlled study. Lancet. 2001, 358: 455-460. 10.1016/S0140-6736(01)05623-9.
    CAS PubMed Google Scholar
  162. Siemers E, Skinner M, Dean R, Gonzales C, Satterwhite J, Farlow M, Ness D, May P: Safety, tolerability, and changes in amyloid beta concentrations after administration of a gamma-secretase inhibitor in volunteers. Clin Neuropharmacol. 2005, 28: 126-132. 10.1097/01.wnf.0000167360.27670.29.
    CAS PubMed Google Scholar
  163. Siemers E, Quinn J, Kaye J, Farlow M, Porsteinsson A, Tariot P, Zoulnouni P, Galvin J, Holtzman D, Knopman D, Satterwhite J, Gonzales C, Dean R, May P: Effects of a gamma-secretase inhibitor in a randomized study of patients with alzheimers disease. Neurology. 2006, 66: 602-604. 10.1212/01.WNL.0000198762.41312.E1.
    CAS PubMed Google Scholar
  164. Geerts H: Drug evaluation: (R)-flurbiprofen–an enantiomer of flurbiprofen for the treatment of alzheimer's disease. IDrugs. 2007, 10: 121-133.
    CAS PubMed Google Scholar
  165. Gómez-Isla T, Blesa R, Boada M, Clarimon J, Del Ser T, Domenech G, Ferro J, Gomez-Anson B, Manubens J, Martinez-Lage J, Munoz D, Pena-Casanova J, Torres F: A randomized, double-blind, placebo controlled-trial of triflusal in mild cognitive impairment: the TRIMCI study. Alzheimer Dis Assoc Disord. 2008, 22: 21-29.
    PubMed Google Scholar
  166. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P: Immunization with amyloid-beta attenuates alzheimer-disease-like pathology in the PDAPP mouse. Nature. 1999, 400: 173-177. 10.1038/22124.
    CAS PubMed Google Scholar
  167. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T: Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nature medicine. 2000, 6: 916-919. 10.1038/78682.
    CAS PubMed Google Scholar
  168. Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, Jones RW, Bullock R, Love S, Neal JW, Zotova E, Nicoll JA: Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet. 2008, 372: 216-23. 10.1016/S0140-6736(08)61075-2.
    CAS PubMed Google Scholar
  169. Koller MF, Mohajeri MH, Huber M, Wollmer MA, Roth Z'graggen BV, Sandmeier E, Moritz E, Tracy J, Nitsch RM, Christen P: Active immunization of mice with an abeta-Hsp70 vaccine. Neurodegener Dis. 2004, 1: 20-28. 10.1159/000076666.
    CAS PubMed Google Scholar
  170. Frenkel D, Dewachter I, van Leuven F, Solomon B: Reduction of beta-amyloid plaques in brain of transgenic mouse model of alzheimer's disease by EFRH-phage immunization. Vaccine. 2003, 21: 1060-1065. 10.1016/S0264-410X(02)00609-6.
    CAS PubMed Google Scholar
  171. Hara H, Monsonego A, Yuasa K, Adachi K, Xiao X, Takeda S, Takahashi K, Weiner HL, Tabira T: Development of a safe oral abeta vaccine using recombinant adeno-associated virus vector for alzheimer's disease. J Alzheimers Dis. 2004, 6: 483-488.
    CAS PubMed Google Scholar
  172. Zhang J, Wu X, Qin C, Qi J, Ma S, Zhang H, Kong Q, Chen D, Ba D, He W: A novel recombinant adeno-associated virus vaccine reduces behavioral impairment and beta-amyloid plaques in a mouse model of alzheimer's disease. Neurobiol Dis. 2003, 14: 365-379. 10.1016/j.nbd.2003.07.005.
    CAS PubMed Google Scholar
  173. Furlan R, Brambilla E, Sanvito F, Roccatagliata L, Olivieri S, Bergami A, Pluchino S, Uccelli A, Comi G, Martino G: Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice. Brain. 2003, 126: 285-291. 10.1093/brain/awg031.
    PubMed Google Scholar
  174. Nikolic WV, Bai Y, Obregon D, Hou H, Mori T, Zeng J, Ehrhart J, Shytle RD, Giunta B, Morgan D, Town T, Tan J: Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage. Proc Natl Acad Sci USA. 2007, 104: 2507-2512. 10.1073/pnas.0609377104.
    PubMed Central CAS PubMed Google Scholar
  175. Town T, Vendrame M, Patel A, Poetter D, DelleDonne A, Mori T, Smeed R, Crawford F, Klein T, Tan J, Mullan M: Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's beta-amyloid(1–42). Reduced Th1 and enhanced Th2 immunity. J Neuroimmunol. 2002, 132: 49-59. 10.1016/S0165-5728(02)00307-7.
    CAS PubMed Google Scholar
  176. Town T, Tan J, Sansone N, Obregon D, Klein T, Mullan M: Characterization of murine immunoglobulin G antibodies against human amyloid-beta1–42. Neurosci Lett. 2002, 307: 101-104. 10.1016/S0304-3940(01)01951-6.
    Google Scholar
  177. DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM: Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science. 2002, 295: 2264-2267. 10.1126/science.1067568.
    CAS PubMed Google Scholar
  178. Vendrame M: Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev. 2005, 14: 595-604. 10.1089/scd.2005.14.595.
    CAS PubMed Google Scholar
  179. Vendrame M, Cassady J, Newcomb J, Butler T, Pennypacker KR, Zigova T, Sanberg CD, Sanberg PR, Willing AE: Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke. 2004, 35: 2390-2395. 10.1161/01.STR.0000141681.06735.9b.
    PubMed Google Scholar
  180. El-Badri NS, Hakki A, Saporta S, Liang X, Madhusodanan S, Willing AE, Sanberg CD, Sanberg PR: Cord blood mesenchymal stem cells: Potential use in neurological disorders. Stem Cells Dev. 2006, 15: 497-506. 10.1089/scd.2006.15.497.
    CAS PubMed Google Scholar
  181. Garbuzova-Davis S, Gografe SJ, Sanberg CD, Willing AE, Saporta S, Cameron DF, Desjarlais T, Daily J, Kuzmin-Nichols N, Chamizo W, Klasko SK, Sanberg PR: Maternal transplantation of human umbilical cord blood cells provides prenatal therapy in sanfilippo type B mouse model. FASEB J. 2006, 20: 485-487.
    CAS PubMed Google Scholar
  182. Henning SM, Aronson W, Niu Y, Conde F, Lee NH, Seeram NP, Lee RP, Lu J, Harris DM, Moro A, Hong J, Pak-Shan L, Barnard RJ, Ziaee HG, Csathy G, Go VL, Wang H, Heber D: Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J Nutr. 2006, 136: 1839-1843.
    CAS PubMed Google Scholar
  183. Nikolic WV, Hou H, Town T, Zhu Y, Giunta B, Sanberg CD, Zeng J, Luo D, Ehrhart J, Mori T, Sanberg PR, Tan J: Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in alzheimer mice. Stem Cells Dev. 2008
    Google Scholar
  184. Tan J, Town T, Paris D, Placzek A, Parker T, Crawford F, Yu H, Humphrey J, Mullan M: Activation of microglial cells by the CD40 pathway: Relevance to multiple sclerosis. J Neuroimmunol. 1999, 97: 77-85. 10.1016/S0165-5728(99)00053-3.
    CAS PubMed Google Scholar
  185. Tan J, Town T, Saxe M, Paris D, Wu Y, Mullan M: Ligation of microglial CD40 results in p44/42 mitogen-activated protein kinase-dependent TNF-alpha production that is opposed by TGF-beta 1 and IL-10. J Immunol. 1999, 163: 6614-6621.
    CAS PubMed Google Scholar
  186. Tan J, Town T, Paris D, Mori T, Suo Z, Crawford F, Mattson MP, Flavell RA, Mullan M: Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science. 1999, 286: 2352-2355. 10.1126/science.286.5448.2352.
    CAS PubMed Google Scholar
  187. Nguyen VT, Walker WS, Benveniste EN: Post-transcriptional inhibition of CD40 gene expression in microglia by transforming growth factor-beta. Eur J Immunol. 1998, 28: 2537-2548. 10.1002/(SICI)1521-4141(199808)28:08<2537::AID-IMMU2537>3.0.CO;2-1.
    CAS PubMed Google Scholar
  188. Carson MJ, Reilly CR, Sutcliffe JG, Lo D: Mature microglia resemble immature antigen-presenting cells. Glia. 1998, 22: 72-85. 10.1002/(SICI)1098-1136(199801)22:1<72::AID-GLIA7>3.0.CO;2-A.
    CAS PubMed Google Scholar
  189. Gerritse K, Laman JD, Noelle RJ, Aruffo A, Ledbetter JA, Boersma WJ, Claassen E: CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci USA. 1996, 93: 2499-2504. 10.1073/pnas.93.6.2499.
    PubMed Central CAS PubMed Google Scholar
  190. Desideri G, Cipollone F, Necozione S, Marini C, Lechiara MC, Taglieri G, Zuliani G, Fellin R, Mezzetti A, di Orio F, Ferri C: Enhanced soluble CD40 ligand and alzheimer's disease: Evidence of a possible pathogenetic role. Neurobiol Aging. 2008, 29: 348-356. 10.1016/j.neurobiolaging.2006.10.019.
    CAS PubMed Google Scholar
  191. Marambaud P, Zhao H, Davies P: Resveratrol promotes clearance of alzheimer's disease amyloid-beta peptides. J Biol Chem. 2005, 280: 37377-37382. 10.1074/jbc.M508246200.
    CAS PubMed Google Scholar
  192. Rezai-Zadeh K, Shytle D, Sun N, Mori T, Hou H, Jeanniton D, Ehrhart J, Townsend K, Zeng J, Morgan D, Hardy J, Town T, Tan J: Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in alzheimer transgenic mice. J Neurosci. 2005, 25: 8807-8814. 10.1523/JNEUROSCI.1521-05.2005.
    CAS PubMed Google Scholar
  193. Obregon DF, Rezai-Zadeh K, Bai Y, Sun N, Hou H, Ehrhart J, Zeng J, Mori T, Arendash GW, Shytle D, Town T, Tan J: ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein. J Biol Chem. 2006, 281: 16419-16427. 10.1074/jbc.M600617200.
    CAS PubMed Google Scholar
  194. Giunta B, Obregon D, Hou H, Zeng J, Sun N, Nikolic V, Ehrhart J, Shytle D, Fernandez F, Tan J: EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and tat in the presence of IFN-gamma: Role of JAK/STAT1 signaling and implications for HIV-associated dementia. Brain Res. 2006, 1123: 216-225. 10.1016/j.brainres.2006.09.057.
    PubMed Central CAS PubMed Google Scholar
  195. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen PP, Kayed R, Glabe CG, Frautschy SA, Cole GM: Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005, 280: 5892-5901. 10.1074/jbc.M404751200.
    CAS PubMed Google Scholar
  196. Beecher GR: Overview of dietary flavonoids: Nomenclature, occurrence and intake. J Nutr. 2003, 133: 3248S-3254S.
    CAS PubMed Google Scholar
  197. Hashimoto F, Ono M, Masuoka C, Ito Y, Sakata Y, Shimizu K, Nonaka G, Nishioka I, Nohara T: Evaluation of the anti-oxidative effect (in vitro) of tea polyphenols. Biosci Biotechnol Biochem. 2003, 67: 396-401. 10.1271/bbb.67.396.
    CAS PubMed Google Scholar
  198. Bors W, Saran M: Radical scavenging by flavonoid antioxidants. Free Radic Res Commun. 1987, 2: 289-294. 10.3109/10715768709065294.
    CAS PubMed Google Scholar
  199. Zheng LT, Ock J, Kwon BM, Suk K: Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int Immunopharmacol. 2008, 8: 484-494. 10.1016/j.intimp.2007.12.012.
    CAS PubMed Google Scholar
  200. Zheng LT, Ock J, Kwon BM, Suk K: Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int Immunopharmacol. 2008, 8: 484-494. 10.1016/j.intimp.2007.12.012.
    CAS PubMed Google Scholar
  201. Kim JS, Jobin C: The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology. 2005, 115: 375-387. 10.1111/j.1365-2567.2005.02156.x.
    PubMed Central CAS PubMed Google Scholar
  202. Kim JY, Kina T, Iwanaga Y, Noguchi H, Matsumura K, Hyon SH: Tea polyphenol inhibits allostimulation in mixed lymphocyte culture. Cell Transplant. 2007, 16: 75-83. 10.3727/000000007783472381.
    PubMed Google Scholar
  203. Mantena SK, Roy AM, Katiyar SK: Epigallocatechin-3-gallate inhibits photocarcinogenesis through inhibition of angiogenic factors and activation of CD8+ T cells in tumors. Photochem Photobiol. 2005, 81: 1174-1179. 10.1562/2005-04-11-RA-487.
    CAS PubMed Google Scholar
  204. Kang TH, Lee JH, Song CK, Han HD, Shin BC, Pai SI, Hung CF, Trimble C, Lim JS, Kim TW, Wu TC: Epigallocatechin-3-gallate enhances CD8+ T cell-mediated antitumor immunity induced by DNA vaccination. Cancer Res. 2007, 67: 802-811. 10.1158/0008-5472.CAN-06-2638.
    PubMed Central CAS PubMed Google Scholar
  205. Min K, Yoon WK, Kim SK, Kim BH: Immunosuppressive effect of silibinin in experimental autoimmune encephalomyelitis. Arch Pharm Res. 2007, 30: 1265-1272. 10.1007/BF02977779.
    CAS PubMed Google Scholar
  206. Watson JL, Ansari S, Cameron H, Wang A, Akhtar M, McKay DM: Green tea polyphenol (-)-epigallocatechin gallate blocks epithelial barrier dysfunction provoked by IFN-gamma but not by IL-4. Am J Physiol Gastrointest Liver Physiol. 2004, 287: G954-961. 10.1152/ajpgi.00302.2003.
    CAS PubMed Google Scholar
  207. Ahn HY, Xu Y, Davidge ST: Epigallocatechin-3-O-gallate inhibits TNFalpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells. Life Sci. 2008, 82: 964-968. 10.1016/j.lfs.2008.02.018.
    CAS PubMed Google Scholar
  208. Xu Z, Chen S, Li X, Luo G, Li L, Le W: Neuroprotective effects of (-)-epigallocatechin-3-gallate in a transgenic mouse model of amyotrophic lateral sclerosis. Neurochem Res. 2006, 31: 1263-1269. 10.1007/s11064-006-9166-z.
    CAS PubMed Google Scholar
  209. Graff JC, Jutila MA: Differential regulation of CD11b on gammadelta T cells and monocytes in response to unripe apple polyphenols. J Leukoc Biol. 2007, 82: 603-607. 10.1189/jlb.0207125.
    CAS PubMed Google Scholar
  210. Yoneyama S, Kawai K, Tsuno NH, Okaji Y, Asakage M, Tsuchiya T, Yamada J, Sunami E, Osada T, Kitayama J, Takahashi K, Nagawa H: Epigallocatechin gallate affects human dendritic cell differentiation and maturation. J Allergy Clin Immunol. 2008, 121: 209-214. 10.1016/j.jaci.2007.08.026.
    CAS PubMed Google Scholar
  211. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G: Correlative memory deficits, abeta elevation, and amyloid plaques in transgenic mice. Science. 1996, 274: 99-102. 10.1126/science.274.5284.99.
    CAS PubMed Google Scholar
  212. Rezai-Zadeh K, Shytle RD, Bai Y, Tian J, Hou H, Mori T, Zeng J, Obregon D, Town T, Tan J: Flavonoid-mediated presenilin-1 phosphorylation reduces alzheimer's disease beta-amyloid production. J Cell Mol Med. 2008
    Google Scholar
  213. Hyun SK, Jung HA, Chung HY, Choi JS: In vitro peroxynitrite scavenging activity of 6-hydroxykynurenic acid and other flavonoids from gingko biloba yellow leaves. Arch Pharm Res. 2006, 29: 1074-1079. 10.1007/BF02969294.
    CAS PubMed Google Scholar
  214. Horvathova K, Novotny L, Tothova D, Vachalkova A: Determination of free radical scavenging activity of quercetin, rutin, luteolin and apigenin in H2O2-treated human ML cells K562. Neoplasma. 2004, 51: 395-399.
    CAS PubMed Google Scholar
  215. Hougee S, Sanders A, Faber J, Graus YM, Berg van den WB, Garssen J, Smit HF, Hoijer MA: Decreased pro-inflammatory cytokine production by LPS-stimulated PBMC upon in vitro incubation with the flavonoids apigenin, luteolin or chrysin, due to selective elimination of monocytes/macrophages. Biochem Pharmacol. 2005, 69: 241-248. 10.1016/j.bcp.2004.10.002.
    CAS PubMed Google Scholar
  216. Verbeek R, Plomp AC, van Tol EA, van Noort JM: The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells. Biochem Pharmacol. 2004, 68: 621-629. 10.1016/j.bcp.2004.05.012.
    CAS PubMed Google Scholar
  217. Hirano T, Higa S, Arimitsu J, Naka T, Ogata A, Shima Y, Fujimoto M, Yamadori T, Ohkawara T, Kuwabara Y, Kawai M, Matsuda H, Yoshikawa M, Maezaki N, Tanaka T, Kawase I, Tanaka T: Luteolin, a flavonoid, inhibits AP-1 activation by basophils. Biochem Biophys Res Commun. 2006, 340: 1-7.
    CAS PubMed Google Scholar
  218. Hirano T, Higa S, Arimitsu J, Naka T, Shima Y, Ohshima S, Fujimoto M, Yamadori T, Kawase I, Tanaka T: Flavonoids such as luteolin, fisetin and apigenin are inhibitors of interleukin-4 and interleukin-13 production by activated human basophils. Int Arch Allergy Immunol. 2004, 134: 135-140. 10.1159/000078498.
    CAS PubMed Google Scholar
  219. Hirata Y, Masuda Y, Kakutani H, Higuchi T, Takada K, Ito A, Nakagawa Y, Ishii H: Sp1 is an essential transcription factor for LPS-induced tissue factor expression in THP-1 monocytic cells, and nobiletin represses the expression through inhibition of NF-kappaB, AP-1, and Sp1 activation. Biochem Pharmacol. 2008, 75: 1504-1514. 10.1016/j.bcp.2007.12.019.
    CAS PubMed Google Scholar
  220. Zheng LT, Ock J, Kwon BM, Suk K: Suppressive effects of flavonoid fisetin on lipopolysaccharide-induced microglial activation and neurotoxicity. Int Immunopharmacol. 2008, 8: 484-494. 10.1016/j.intimp.2007.12.012.
    CAS PubMed Google Scholar
  221. Kim JS, Jobin C: The flavonoid luteolin prevents lipopolysaccharide-induced NF-kappaB signalling and gene expression by blocking IkappaB kinase activity in intestinal epithelial cells and bone-marrow derived dendritic cells. Immunology. 2005, 115: 375-387. 10.1111/j.1365-2567.2005.02156.x.
    PubMed Central CAS PubMed Google Scholar
  222. Goyarzu P, Malin DH, Lau FC, Taglialatela G, Moon WD, Jennings R, Moy E, Moy D, Lippold S, Shukitt-Hale B, Joseph JA: Blueberry supplemented diet: Effects on object recognition memory and nuclear factor-kappa B levels in aged rats. Nutr Neurosci. 2004, 7: 75-83. 10.1080/10284150410001710410.
    PubMed Google Scholar
  223. Joseph JA, Denisova NA, Arendash G, Gordon M, Diamond D, Shukitt-Hale B, Morgan D: Blueberry supplementation enhances signaling and prevents behavioral deficits in an alzheimer disease model. Nutr Neurosci. 2003, 6: 153-162. 10.1080/1028415031000111282.
    CAS PubMed Google Scholar
  224. Obregon DF, Rezai-Zadeh K, Bai Y, Sun N, Hou H, Ehrhart J, Zeng J, Mori T, Arendash GW, Shytle D, Town T, Tan J: ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein. J Biol Chem. 2006, 281: 16419-16427. 10.1074/jbc.M600617200.
    CAS PubMed Google Scholar
  225. Joseph JA, Shukitt-Hale B, Denisova NA, Bielinski D, Martin A, McEwen JJ, Bickford PC: Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci. 1999, 19: 8114-8121.
    CAS PubMed Google Scholar
  226. Laurin D, Masaki KH, Foley DJ, White LR, Launer LJ: Midlife dietary intake of antioxidants and risk of late-life incident dementia: The honolulu-asia aging study. Am J Epidemiol. 2004, 159: 959-967. 10.1093/aje/kwh124.
    PubMed Google Scholar
  227. White LR, Petrovitch H, Ross GW, Masaki K, Hardman J, Nelson J, Davis D, Markesbery W: Brain aging and midlife tofu consumption. J Am Coll Nutr. 2000, 19: 242-255.
    CAS PubMed Google Scholar
  228. Engelhart MJ, Geerlings MI, Ruitenberg A, van Swieten JC, Hofman A, Witteman JC, Breteler MM: Dietary intake of antioxidants and risk of alzheimer disease. JAMA. 2002, 287: 3223-3229. 10.1001/jama.287.24.3223.
    CAS PubMed Google Scholar
  229. Commenges D, Scotet V, Renaud S, Jacqmin-Gadda H, Barberger-Gateau P, Dartigues JF: Intake of flavonoids and risk of dementia. Eur J Epidemiol. 2000, 16: 357-363. 10.1023/A:1007614613771.
    CAS PubMed Google Scholar

Download references